UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000002788 |
|---|---|
| Receipt number | R000003389 |
| Scientific Title | Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods |
| Date of disclosure of the study information | 2009/11/20 |
| Last modified on | 2010/06/24 11:38:46 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods
Acronym
Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods
Scientific Title
Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods
Scientific Title:Acronym
Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods
Region
| Japan |
Condition
Condition
schizophrenia
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
Elucidation of pathogenesis of schizophrenia using biological and symtomatological methods
Basic objectives2
Others
Basic objectives -Others
Clarifying the pathogenesis of schizophrenia using genetical, symptomatological, physiological and pharmacological approaches
Trial characteristics_1
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Candidate genes, exploratory eye movement, PANSS, SAPS, DIEPSS
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Schizophrenia patients diagnosed by ICD-10
Key exclusion criteria
Psychiatric patient who has a history of alcohol or illicit substance abuse, head injury, convulsion, or neurologic or ophthalmologic disorder.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Sakae Takahashi |
Organization
Nihon University School of Medicine
Division name
Department of Neuropsychiatry
Zip code
Address
30-1 Oyaguchi- Kamicho, Itabashi-ku, Tokyo 173-8610, Japan
TEL
+81-3-3972-8111
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Nihon University School of Medicine
Division name
Department of Neuropsychiatry
Zip code
Address
30-1 Oyaguchi- Kamicho, Itabashi-ku, Tokyo 173-8610, Japan
TEL
+81-3-3972-8111
Homepage URL
Sponsor or person
Institute
Nihon University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Jiundo-Naika Hospital
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
日本大学医学部附属板橋病院（東京都）、慈雲堂内科病院（東京都）
Other administrative information
Date of disclosure of the study information
| 2009 | Year | 11 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2009 | Year | 09 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2009 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2014 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Clarifying the pathogenesis of schizophrenia using genetical, symptomatological, physiological and pharmacological approaches
Management information
Registered date
| 2009 | Year | 11 | Month | 20 | Day |
Last modified on
| 2010 | Year | 06 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003389
